moclobemide

As the list published 23 Sept 2026 has it, binding since 21 Jun 2023. Each entry binds six months after its own publication date (Article 107c(7) of Directive 2001/83/EC).

What the list says

EU reference date: 26 Oct 1989
PSUR frequency: 5 years
Data lock point: 1 Apr 2027
Submission date: 30 Jun 2027
Next data lock point: Not stated
Next submission date: Not stated
Products covered: Nationally authorised (NAP)

Are PSURs required for products referred to in Articles 10(1), 10a and 16a of Directive 2001/83/EC?

No — the list does not require PSURs for these products.

The list asks this as one question for Articles 10(1), 10a and 16a together, and does not answer it for Article 14 at all. A PSUR may in any case be required at the request of a competent authority or as a condition of the marketing authorisation.

Notes in the list

DLP was updated on 21/12/2022 PRAC Rapporteur name updated on 23/10/2018 PRAC Representative updated on 26/09/2018 DLP was updated on 19/12/2017 Lead MS and PRAC Rapporteur name was added on 19/10/2016

Track dates like these for your own products: a sample workspace, read-only, no account needed.

Try the demo

The next three reports

Data lock point 1 Apr 2027Submission by 30 Jun 2027
Data lock point 1 Apr 2032Submission by 30 Jun 2032
Data lock point 1 Apr 2037Submission by 30 Jun 2037

Counted from the data lock point the list gives, on the cycle it states: the submission date is 90 days after the data lock point — 70 days for a cycle of twelve months or less, 90 days for a longer one, as GVP Module VII sets out.

In earlier versions of the list

EMA/630645/2012 Rev.164 · published 23 Sept 2026
moclobemide — every 5 years, data lock point 1 Apr 2027
EMA/630645/2012 Rev.156 · published 4 Feb 2026
moclobemide — every 5 years, data lock point 1 Apr 2027

Source: European Medicines Agency, list of EU reference dates and frequency of submission of periodic safety update reports, EMA/630645/2012 Rev.164, published 23 Sept 2026. Open the published file

Kreastel is a planning and oversight aid for pharmacovigilance obligations. It tracks dates like these for a marketing authorisation holder's own products.

Report a discrepancy — if this page and the published file disagree, the file is right and we want to know.

Kreastel